Latest Deep Track Capital, LP Stock Portfolio
Deep Track Capital, LP Performance:
2025 Q1: -8.99%YTD: -8.99%2024: -1.58%
Performance for 2025 Q1 is -8.99%, and YTD is -8.99%, and 2024 is -1.58%.
About Deep Track Capital, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Deep Track Capital, LP reported an equity portfolio of $3.1 Billions as of 31 Mar, 2025.
The top stock holdings of Deep Track Capital, LP are ITCI, GH, DVAX. The fund has invested 8.5% of it's portfolio in INTRA-CELLULAR THERAPIES INC and 7.5% of portfolio in GUARDANT HEALTH INC .
The fund managers got completely rid off SPRINGWORKS THERAPEUTICS INC (SWTX), HARMONY BIOSCIENCES HLDGS IN (HRMY) and GENMAB A/S stocks. They significantly reduced their stock positions in BICYCLE THERAPEUTICS PLC (BCYC), NOVAVAX INC (NVAX) and GUARDANT HEALTH INC (GH). Deep Track Capital, LP opened new stock positions in TARSUS PHARMACEUTICALS INC (TARS), SAREPTA THERAPEUTICS INC (SRPT) and DIANTHUS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to GERON CORP (GERN), XENON PHARMACEUTICALS INC (XENE) and BRIDGEBIO PHARMA INC (BBIO).
The top stock holdings of Deep Track Capital, LP are ITCI, GH, DVAX. The fund has invested 8.5% of it's portfolio in INTRA-CELLULAR THERAPIES INC and 7.5% of portfolio in GUARDANT HEALTH INC .
The fund managers got completely rid off SPRINGWORKS THERAPEUTICS INC (SWTX), HARMONY BIOSCIENCES HLDGS IN (HRMY) and GENMAB A/S stocks. They significantly reduced their stock positions in BICYCLE THERAPEUTICS PLC (BCYC), NOVAVAX INC (NVAX) and GUARDANT HEALTH INC (GH). Deep Track Capital, LP opened new stock positions in TARSUS PHARMACEUTICALS INC (TARS), SAREPTA THERAPEUTICS INC (SRPT) and DIANTHUS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to GERON CORP (GERN), XENON PHARMACEUTICALS INC (XENE) and BRIDGEBIO PHARMA INC (BBIO).
Deep Track Capital, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Deep Track Capital, LP made a return of -8.99% in the last quarter. In trailing 12 months, it's portfolio return was -12.86%.
New Buys
| Ticker | $ Bought |
|---|---|
| tarsus pharmaceuticals inc | 76,246,700 |
| sarepta therapeutics inc | 57,420,800 |
| dianthus therapeutics inc | 42,768,700 |
| maze therapeutics inc | 35,993,100 |
| amgen inc | 35,216,100 |
| metsera inc | 29,789,800 |
| vaxcyte inc | 28,320,000 |
| compass pathways plc | 25,338,600 |
New stocks bought by Deep Track Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| geron corp | 851 |
| xenon pharmaceuticals inc | 491 |
| bridgebio pharma inc | 241 |
| protagonist therapeutics inc | 200 |
| immunocore hldgs plc | 171 |
| ionis pharmaceuticals inc | 136 |
| upstream bio inc | 129 |
| akero therapeutics inc | 115 |
Additions to existing portfolio by Deep Track Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| bicycle therapeutics plc | -39.89 |
| novavax inc | -24.09 |
| guardant health inc | -15.2 |
| mind medicine mindmed inc | -11.24 |
| pliant therapeutics inc | -9.59 |
| invivyd inc | -9.05 |
| galapagos nv | -5.09 |
| avalo therapeutics inc | -0.82 |
Deep Track Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| springworks therapeutics inc | -125,037,000 |
| genmab a/s | -41,740,000 |
| nektar therapeutics | -1,837,680 |
| harmony biosciences hldgs in | -49,894,500 |
| centessa pharmaceuticals plc | -22,612,500 |
| verona pharma plc | -39,474,000 |
| 4d molecular therapeutics in | -3,397,140 |
Deep Track Capital, LP got rid off the above stocks
Sector Distribution
Deep Track Capital, LP has about 86.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 86.4 |
| Others | 13.4 |
Market Cap. Distribution
Deep Track Capital, LP has about 3.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 48.7 |
| SMALL-CAP | 30.5 |
| UNALLOCATED | 15.6 |
| LARGE-CAP | 3.6 |
| MICRO-CAP | 1.1 |
Stocks belong to which Index?
About 69.1% of the stocks held by Deep Track Capital, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 68 |
| Others | 30.9 |
| S&P 500 | 1.1 |
Deep Track Capital, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Deep Track Capital, LP
Deep Track Capital, LP has 69 stocks in it's portfolio. About 53.1% of the portfolio is in top 10 stocks. PLRX proved to be the most loss making stock for the portfolio. ITCI was the most profitable stock for Deep Track Capital, LP last quarter.
Last Reported on: 15 May, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ITCI | intra-cellular therapies inc | 8.54 | 2,000,000 | 263,840,000 | unchanged | 0.00 | ||
Historical Trend of INTRA-CELLULAR THERAPIES INC Position Held By Deep Track Capital, LPWhat % of Portfolio is ITCI?:Number of ITCI shares held:Change in No. of Shares Held: | ||||||||
| GH | guardant health inc | 7.51 | 5,443,720 | 231,903,000 | reduced | -15.2 | ||
| DVAX | dynavax technologies corp | 7.47 | 17,791,500 | 230,756,000 | unchanged | 0.00 | ||
| IMVT | immunovant inc | 5.26 | 9,500,000 | 162,355,000 | added | 58.33 | ||
| PTGX | protagonist therapeutics inc | 4.70 | 3,000,000 | 145,080,000 | added | 200 | ||
| IONS | ionis pharmaceuticals inc | 4.46 | 4,564,210 | 137,702,000 | added | 136 | ||
| AKRO | akero therapeutics inc | 4.21 | 3,210,270 | 129,952,000 | added | 115 | ||
| CYTK | cytokinetics inc | 4.00 | 3,073,850 | 123,538,000 | added | 22.95 | ||
| APLS | apellis pharmaceuticals inc | 3.54 | 5,000,000 | 109,350,000 | added | 16.96 | ||
| OCUL | ocular therapeutix inc | 3.39 | 14,294,400 | 104,778,000 | added | 11.36 | ||
| BBIO | bridgebio pharma inc | 3.13 | 2,800,000 | 96,796,000 | added | 241 | ||
| TARS | tarsus pharmaceuticals inc | 2.47 | 1,484,270 | 76,246,700 | new | |||
| VRDN | viridian therapeutics inc | 2.35 | 5,380,450 | 72,528,500 | added | 18.96 | ||
| structure therapeutics inc | 2.30 | 4,100,000 | 70,971,000 | added | 46.43 | |||
| ETNB | 89bio inc | 2.19 | 9,316,330 | 67,729,700 | added | 43.81 | ||
| NRIX | nurix therapeutics inc | 2.12 | 5,500,000 | 65,340,000 | added | 83.33 | ||
| GERN | geron corp | 1.97 | 38,176,300 | 60,700,200 | added | 851 | ||
| SRPT | sarepta therapeutics inc | 1.86 | 899,731 | 57,420,800 | new | |||
| RARE | ultragenyx pharmaceutical in | 1.58 | 1,350,000 | 48,883,500 | added | 106 | ||
| ANIP | ani pharmaceuticals inc | 1.52 | 700,000 | 46,865,000 | added | 7.85 | ||
